Italian skin disease registry aims to map treatment journeys for 20,000 patients

NCT ID NCT07336641

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will collect existing medical records from about 20,000 people aged 12 and older in Italy who have one of five inflammatory skin conditions: psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to describe who gets these diseases, what treatments they receive, and how their condition changes over time. No new treatments are being tested; the goal is simply to learn from real-world patient data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • IRCCS Istituto Clinico Humanitas - Dermatology Unit

    Rozzano, Lombardy, 20089, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.